4.6 Article

Interstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Detection of Post-COVID-19 Lung Abnormalities: Photon-counting CT versus Same-Day Energy-integrating Detector CT

Florian Prayer et al.

Summary: Photon-counting detector CT outperforms energy-integrating detector CT in the visualization of subtle post-COVID-19 lung abnormalities and image quality.

RADIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection

Maria T. Tsakok et al.

Summary: This study compared the chest CT radiologic findings, biochemical parameters, clinical severity, and hospital outcomes between the SARS-CoV-2 Omicron variant and the Delta variant. The results showed that the Omicron variant demonstrated fewer and less severe changes on chest CT images compared to the Delta variant. Patients with Omicron infection had improved hospital outcomes and less severe disease compared to patients with Delta infection.

RADIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Chest CT Findings in Hospitalized Patients with SARS-CoV-2: Delta versus Omicron Variants

Soon Ho Yoon et al.

Summary: This study compared the chest CT findings of SARS-CoV-2 between Delta and Omicron variants. The results showed that compared to the Delta variant, the Omicron variant exhibited non-typical peribronchovascular pneumonia and less pulmonary vascular involvement on CT.

RADIOLOGY (2023)

Article Oncology

Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience

Mehmet Altan et al.

Summary: This study retrospectively analyzed 419 patients with advanced non-small cell lung cancer who received immune checkpoint inhibitor therapy and found a high incidence of pneumonitis, which significantly increased the risk of death. The risk of pneumonitis was higher in patients without a smoking history and patients with interstitial lung disease.

ONCOLOGIST (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Longitudinal Assessment of Chest CT Findings and Pulmonary Function after COVID-19 Infection

Xiaoyu Han et al.

Summary: This prospective study longitudinally assessed changes in chest CT abnormalities and pulmonary function in individuals after recovery from SARS-CoV-2 infection. The study found that more than one-third of the participants had persistent interstitial lung abnormalities 2 years after infection, which were associated with respiratory symptoms and decreased diffusion pulmonary function.

RADIOLOGY (2023)

Article Critical Care Medicine

Residual Lung Abnormalities after COVID-19 Hospitalization Interim Analysis of the UKILD Post-COVID-19 Study

Iain Stewart et al.

Summary: This study analyzed the data from the UK Interstitial Lung Disease Consortium (UKILD) post-COVID-19 study to estimate the prevalence of residual lung abnormalities in hospitalized COVID-19 patients. The results showed that approximately 11% of recovered COVID-19 patients had residual lung abnormalities, highlighting the need for long-term monitoring.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Chest CT of Lung Injury 1 Year after COVID-19 Pneumonia: The CovILD Study

Anna K. Luger et al.

Summary: This study aimed to evaluate the improvement of chest CT abnormalities 1 year after COVID-19 pneumonia. The study found that more than half of the participants still had CT abnormalities after 1 year, and age over 60, severe COVID-19 symptoms, and male sex were associated with persistent CT abnormalities at 1-year follow-up. During the follow-up period, about half of the participants had complete resolution of CT abnormalities, but some participants with abnormalities showed no further improvement after 6 months.

RADIOLOGY (2022)

Article Critical Care Medicine

Prevalence and Mechanisms of Mucus Accumulation in COVID-19 Lung Disease

Takafumi Kato et al.

Summary: This study investigated the incidence of mucus accumulation and the molecular mechanisms of mucin hypersecretion in COVID-19 lung disease. The researchers found that MUC5B gene expression increased in the airways of COVID-19 autopsy lungs. SARS-CoV-2 infection was associated with distal airspace mucus accumulation, and the EGFR and IL-1R signaling pathways played important roles in mucin gene regulation.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Persistent 129Xe MRI Pulmonary and CT Vascular Abnormalities in Symptomatic Individuals with Post-acute COVID-19 Syndrome

Alexander M. Matheson et al.

Summary: This study investigated the relationship between persistent symptoms and exercise limitation with xenon 129 (Xe-129) MRI and CT pulmonary vascular measurements in individuals with post-acute COVID-19 syndrome (PACS). The results showed that Xe-129 MRI measurements were lower in PACS patients previously hospitalized with COVID-19 compared to healthy controls. These measurements were associated with CT pulmonary vascular density, diffusing capacity of the lung for carbon monoxide, exercise capacity, and dyspnea.

RADIOLOGY (2022)

Article Critical Care Medicine

Clinical status of patients 1 year after hospital discharge following recovery from COVID-19: a prospective cohort study

Dapeng Li et al.

Summary: This prospective cohort study evaluated the long-term clinical status of COVID-19 in recovered patients. The study found that one year after hospital discharge, patients continued to experience pulmonary and extrapulmonary dysfunction. Common symptoms reported included fatigue and sleep difficulties. Abnormal chest CT scans were found in the majority of patients, and kidney function declined persistently after discharge.

ANNALS OF INTENSIVE CARE (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Interstitial Lung Abnormalities at CT: Subtypes, Clinical Significance, and Associations with Lung Cancer

Akinori Hata et al.

Summary: Interstitial lung abnormality (ILA) refers to interstitial changes incidentally detected on CT images. It occurs in 4%-9% of smokers and 2%-7% of nonsmokers. ILA tends to worsen over time and is associated with respiratory symptoms, reduced exercise capacity, decreased pulmonary function, and increased mortality. ILA can be categorized into nonsubpleural, subpleural nonfibrotic, and subpleural fibrotic types. Clinically significant interstitial lung disease should be identified and managed by a pulmonologist in cases of ILA. Risk factors for ILA progression include clinical factors (such as inhalation exposures, medication use, radiation therapy, thoracic surgery, physiological findings, and gas exchange findings) and radiological factors (such as basal and peripheral predominance and fibrotic findings). It is recommended to actively monitor individuals with one or more clinical or radiological risk factors for ILA progression using pulmonary function testing and CT.

RADIOGRAPHICS (2022)

Article Respiratory System

Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial

Thomas Sonnweber et al.

Summary: A study found that some COVID-19 patients still experienced persistent symptoms and lung function impairment 100 days after the onset of the disease, but there was significant improvement in symptoms and cardiopulmonary status over time.

EUROPEAN RESPIRATORY JOURNAL (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Six-month Follow-up Chest CT Findings after Severe COVID-19 Pneumonia

Xiaoyu Han et al.

Summary: The study found that over one-third of severe COVID-19 patients showed fibrotic-like changes in the lung at 6-month follow-up CT, which were associated with older age, acute respiratory distress syndrome, longer hospital stays, tachycardia, noninvasive mechanical ventilation, and higher initial chest CT score.

RADIOLOGY (2021)

Article Oncology

COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)

Livio Pagano et al.

Summary: This study analyzed baseline characteristics and predictors of mortality in hematological malignancy patients with COVID-19. Results showed that a high percentage of patients developed severe/critical symptoms, with a mortality rate of 31.2%, although improved prevention measures have decreased mortality rates despite an increase in reported cases.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Medicine, Research & Experimental

Virus infection induced pulmonary fibrosis

Wei Jie Huang et al.

Summary: Pulmonary fibrosis, the end stage of various lung diseases, may be triggered by virus infection, but the specific mechanisms are not fully understood. Studying the relationship between pulmonary fibrosis and various viruses, as well as the infection mechanisms, may provide insights into potential anti-fibrotic treatment targets.

JOURNAL OF TRANSLATIONAL MEDICINE (2021)

Article Respiratory System

Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length

Claire F. McGroder et al.

Summary: Patients who underwent mechanical ventilation for severe COVID-19 are more likely to develop fibrotic-like radiographic abnormalities after hospitalisation. The severity of initial illness, duration of mechanical ventilation, lactate dehydrogenase on admission, and leucocyte telomere length are independent risk factors for these abnormalities, which are correlated with lung function, cough, and frailty measures, but not with dyspnoea.

THORAX (2021)

Article Respiratory System

Persistent Post-COVID-19 Interstitial Lung Disease An Observational Study of Corticosteroid Treatment

Katherine Jane Myall et al.

Summary: Following SARS-CoV-2 infection, some patients develop persistent radiological inflammatory lung disease and functional deficits. Early treatment with corticosteroids is well tolerated and associated with rapid and significant improvement.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Editorial Material Immunology

SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis

M. Victoria Delpino et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Article Critical Care Medicine

Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society

Hiroto Hatabu et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis

Max A. Seibold et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Critical Care Medicine

Telomere shortening in familial and sporadic pulmonary fibrosis

Jennifer T. Cronkhite et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Multidisciplinary Sciences

Short telomeres are a risk factor for idiopathic pulmonary fibrosis

Jonathan K. Alder et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Medicine, General & Internal

Telomerase mutations in families with idiopathic pulmonary fibrosis

Mary Y. Armanios et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)